Lifetime cost-effectiveness simulation of once-weekly exenatide in type 2 diabetes: A cost-utility analysis based on the EXSCEL trial
Autor: | Becker, Frauke, Dakin, Helen A., Reed, Shelby D., Li, Yanhong, Leal, José, Gustavson, Stephanie M., Wittbrodt, Eric, Hernandez, Adrian F., Gray, Alastair M., Holman, Rury R. |
---|---|
Zdroj: | In Diabetes Research and Clinical Practice January 2022 183 |
Databáze: | ScienceDirect |
Externí odkaz: |